The CTN collaborated with the Division of Pharmacotherapies & Medical Consequences of Drug Abuse (DPMCDA) on this multi-centered trial to compare the effect of buprenorphine/naloxone (Bup/Nx) and methadone (MET) on liver function. This was a randomized, open-label, multi-center, Phase 4 study in participants entering opioid agonist treatment programs at community centers (methadone centers) throughout the country. The study randomized approximately 1,300 participants at 8 sites across 6 Nodes.
Participating Nodes and Community Treatment Programs
Pacific Region Node (Lead Node)
California-Arizona Node (Inactive)
New England Node (Inactive)
Oregon-Hawaii Node (Inactive)
Get this Publication
Formed with SAMHSA to reduce the gap between research results and treatment.